As General Motors Co (GM) Valuation Declined, Financial Partners Capital Management Has Trimmed by $372,120 Its Position; Boston Scientific (BSX) Share Price Rose While Associated Banc-Corp Has Lifted Its Holding

General Motors Company (NYSE:GM) Logo

Associated Banc-Corp increased its stake in Boston Scientific Corp (BSX) by 11.56% based on its latest 2017Q4 regulatory filing with the SEC. Associated Banc-Corp bought 35,163 shares as the company’s stock rose 7.69% while stock markets declined. The institutional investor held 339,380 shares of the medical and dental instruments company at the end of 2017Q4, valued at $8.41 million, up from 304,217 at the end of the previous reported quarter. Associated Banc-Corp who had been investing in Boston Scientific Corp for a number of months, seems to be bullish on the $40.32B market cap company. The stock decreased 0.75% or $0.22 during the last trading session, reaching $29.23. About 7.47M shares traded. Boston Scientific Corporation (NYSE:BSX) has risen 9.97% since April 28, 2017 and is uptrending. It has underperformed by 1.58% the S&P500.

Financial Partners Capital Management Llc decreased its stake in General Motors Co (GM) by 4.8% based on its latest 2017Q4 regulatory filing with the SEC. Financial Partners Capital Management Llc sold 9,303 shares as the company’s stock declined 17.02% with the market. The institutional investor held 184,657 shares of the auto manufacturing company at the end of 2017Q4, valued at $7.57M, down from 193,960 at the end of the previous reported quarter. Financial Partners Capital Management Llc who had been investing in General Motors Co for a number of months, seems to be less bullish one the $52.73B market cap company. The stock decreased 1.57% or $0.6 during the last trading session, reaching $37.65. About 8.66 million shares traded. General Motors Company (NYSE:GM) has risen 0.46% since April 28, 2017 and is uptrending. It has underperformed by 11.09% the S&P500.

Associated Banc-Corp, which manages about $1.85B US Long portfolio, decreased its stake in Qualcomm Inc (NASDAQ:QCOM) by 6,693 shares to 11,218 shares, valued at $718,000 in 2017Q4, according to the filing. It also reduced its holding in Waste Mgmt Inc Del (NYSE:WM) by 4,230 shares in the quarter, leaving it with 78,191 shares, and cut its stake in Berkshire Hathaway Inc Del (BRKB).

Investors sentiment increased to 1.34 in 2017 Q4. Its up 0.30, from 1.04 in 2017Q3. It is positive, as 36 investors sold BSX shares while 158 reduced holdings. 86 funds opened positions while 174 raised stakes. 1.18 billion shares or 2.38% less from 1.21 billion shares in 2017Q3 were reported. Moreover, Jefferies Gru Ltd Liability has 0.03% invested in Boston Scientific Corporation (NYSE:BSX) for 265,687 shares. Geller Family Office Svcs Ltd holds 2.76 million shares or 34.47% of its portfolio. Employees Retirement Sys Of Ohio holds 990,613 shares. Nj State Employees Deferred Compensation Plan invested in 0.17% or 40,000 shares. Fuller Thaler Asset Management has 156,995 shares. Bluecrest Cap Mngmt Ltd reported 21,259 shares. Comerica Bancorporation, Michigan-based fund reported 365,319 shares. Factory Mutual Ins Comm invested 0.14% in Boston Scientific Corporation (NYSE:BSX). Meag Munich Ergo Kapitalanlagegesellschaft Mbh, Germany-based fund reported 65,713 shares. Wade G W & Inc reported 13,063 shares. Pacad Inv Ltd stated it has 77,600 shares or 0.44% of all its holdings. Royal Financial Bank Of Canada owns 935,967 shares for 0.01% of their portfolio. Stevens Capital Mngmt Limited Partnership invested 0.29% in Boston Scientific Corporation (NYSE:BSX). Btim Corp accumulated 12,002 shares. Susquehanna Limited Liability Partnership reported 0% stake.

Since October 30, 2017, it had 0 insider buys, and 14 insider sales for $7.38 million activity. Shares for $381,949 were sold by Sorenson John Bradley. Phalen Michael P. sold $399,865 worth of Boston Scientific Corporation (NYSE:BSX) on Friday, December 29. Another trade for 85,227 shares valued at $2.26M was sold by Fitzgerald Joseph Michael. Another trade for 42,803 shares valued at $1.21 million was made by Ballinger Kevin J. on Wednesday, March 14. On Monday, March 19 Brennan Daniel J. sold $1.68M worth of Boston Scientific Corporation (NYSE:BSX) or 60,209 shares.

Among 32 analysts covering Boston Scientific Corporation (NYSE:BSX), 26 have Buy rating, 0 Sell and 6 Hold. Therefore 81% are positive. Boston Scientific Corporation had 98 analyst reports since July 27, 2015 according to SRatingsIntel. The stock of Boston Scientific Corporation (NYSE:BSX) has “Buy” rating given on Thursday, April 5 by Bank of America. The firm has “Outperform” rating by BMO Capital Markets given on Friday, October 27. The firm has “Hold” rating given on Thursday, August 13 by TheStreet. SunTrust initiated Boston Scientific Corporation (NYSE:BSX) on Thursday, February 25 with “Buy” rating. Morgan Stanley maintained Boston Scientific Corporation (NYSE:BSX) rating on Monday, March 19. Morgan Stanley has “Overweight” rating and $33 target. The stock has “Buy” rating by Stifel Nicolaus on Thursday, April 28. BTIG Research upgraded Boston Scientific Corporation (NYSE:BSX) on Thursday, November 30 to “Buy” rating. SunTrust maintained the shares of BSX in report on Tuesday, October 31 with “Buy” rating. The rating was maintained by Cowen & Co on Wednesday, November 29 with “Buy”. The firm earned “Outperform” rating on Friday, June 9 by RBC Capital Markets.

Among 29 analysts covering General Motors Company (NYSE:GM), 17 have Buy rating, 3 Sell and 9 Hold. Therefore 59% are positive. General Motors Company had 94 analyst reports since July 24, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Tuesday, January 16 by CFRA. RBC Capital Markets maintained General Motors Company (NYSE:GM) rating on Thursday, October 22. RBC Capital Markets has “Sector Perform” rating and $39 target. Nomura maintained the shares of GM in report on Thursday, February 8 with “Neutral” rating. Morgan Stanley maintained the shares of GM in report on Wednesday, February 14 with “Equal-Weight” rating. Piper Jaffray maintained the stock with “Buy” rating in Tuesday, October 24 report. Jefferies maintained the stock with “Hold” rating in Monday, August 28 report. UBS maintained the shares of GM in report on Thursday, October 22 with “Buy” rating. The stock of General Motors Company (NYSE:GM) has “Hold” rating given on Thursday, September 14 by Standpoint Research. Morgan Stanley upgraded the stock to “Equal-Weight” rating in Friday, May 6 report. The stock has “Neutral” rating by Deutsche Bank on Monday, September 21.

General Motors Company (NYSE:GM) Institutional Positions Chart